Pancreatic Cancer Study Reaches 10,000 Participants Worldwide
The PRECEDE Consortium doubles its enrollment target to 20,000 as it builds a dataset for early detection tool development.
Read MorePosted by CLP Edit Staff | Oct 2, 2025 | Pancreatic |
The PRECEDE Consortium doubles its enrollment target to 20,000 as it builds a dataset for early detection tool development.
Read MorePosted by CLP Edit Staff | Oct 1, 2025 | Lung Cancer |
A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.
Read MorePosted by CLP Edit Staff | Sep 30, 2025 | Gastrointestinal Infections |
The new test expands from four genes to nine while maintaining clinical focus, addressing diagnostic challenges with PRSS1 testing accuracy.
Read MorePosted by CLP Edit Staff | Sep 26, 2025 | Molecular Diagnostic Analyzers |
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
Read MorePosted by CLP Edit Staff | Sep 26, 2025 | Sequencing Systems |
New research demonstrates the ultra-sensitive SNV detection capabilities of ppmSeq technology, with error rates reaching as low as 8 x 10-8 for minimal residual disease applications.
Read More